The Digital Source For China's Tech Innovation Since 2000

China Tech Buzz

Global News Impacting Chinese Tech

AI could end up too cheap to control

July 30, 2026
Source: vox.com vox.com
News Snapshot:
The AI industry’s investors and critics don’t agree on much. But many in each camp share at least one basic conviction: America’s top labs are about to make a killing.Capital markets have signaled their faith in Anthropic and OpenAI’s impending hyper-profitability, valuing each at nearly $1 trillion. Many of Silicon Valley’s progressive adversaries also expect the labs to grow filthy rich but fear the implications, warning that AI-induced automation could transfer vast sums of money from ordinary workers to a handful of giant tech companies. Sen. Bernie Sanders’s call for nationalizing the top AI labs rests partly on that concern.Key...
GO TO ORIGINAL SOURCE →
China Tech Buzz Topics: AI | AI Labs | Airbnb | Alibaba | America | app | automation | block | Business | California | capital | Chinese | cloud | Cloud Computing | computer | Computing | court | currency | cybersecurity | data | development | display | Donald Trump | Economy | EDGE

Other News:

Investigation Launched into DoorDash's Use of Moonshot AI's Kimi K2.6 Model

August 1, 2026

Brookfield, Cameco plan IPO of jointly owned nuclear power company Westinghouse

August 1, 2026
theglobeandmail.com theglobeandmail.com

Trump AI executive order nears key deadline regulation debate heats up

August 1, 2026
cnbc.com cnbc.com

Google plans to exempt sanctioned nations from Android developer verification

August 1, 2026
arstechnica.com arstechnica.com

The FCC Just Banned Most Robot Vacuums. Here's What That Means

August 1, 2026
cnet.com cnet.com

Twitch Streamer Ludwig Appears As An NPC In A Chinese FMV Game

August 1, 2026
kotaku.com kotaku.com

Why Australia ships out its wealth – and buys it back as finished goods

August 1, 2026
sbs.com.au sbs.com.au

Palantir CTO says the power grid is a bigger AI threat than China

August 1, 2026
foxnews.com foxnews.com

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease

August 1, 2026
manilatimes.net manilatimes.net
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2026 ChinaTechNews.com. A Service of Asia Media Network.